ELI LILLY & Co·4

Feb 14, 4:52 PM ET

Norton Johna 4

4 · ELI LILLY & Co · Filed Feb 14, 2023

Insider Transaction Report

Form 4
Period: 2023-02-10
Norton Johna
Senior VP, Global Quality
Transactions
  • Award

    Common Stock

    2023-02-10$345.12/sh+2,507$865,21633,908 total
  • Award

    Restricted Stock Unit

    2023-02-10+1,2681,268 total
    From: 2024-02-01Exp: 2024-02-01Common Stock (1,268 underlying)
Holdings
  • Common Stock

    (indirect: by partner)
    128
  • Common Stock

    (indirect: By 401(k))
    1,756
  • Common Stock

    (indirect: By 401(k))
    399
Footnotes (2)
  • [F1]Reporting person disclaims beneficial ownership of these shares.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.

Documents

1 file
  • 4
    wf-form4_167641155807782.xmlPrimary

    FORM 4